Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Drug Delivery Systems was a U.S.-based specialty pharmaceutical company focused on drug delivery technologies and specialty pharma products. Publicly available information indicates the company operated in the healthcare and biotech/pharma sector and was incorporated in 1999, with a New York address later associated with the business. Corporate registry records show inactive status for at least its Massachusetts foreign registration, suggesting the company is no longer operating as an active standalone business. Detailed recent information on its product portfolio, development pipeline, partnerships, and financial profile is scarce in accessible public sources, so the company appears to have been a small or thinly disclosed specialty pharma entity centered on drug delivery rather than a broadly documented clinical-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Drug Delivery Systems.